PH29938A - Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives - Google Patents

Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives

Info

Publication number: PH29938A
Authority: PH; Philippines
Prior art keywords: hydrogen; fluorine; alkyl; 5alpha; 17beta
Prior art date: 1992-07-31

Application number

PH46606A

Other languages

English (en)

Inventor

Achille Panzeri

Marcella Nesi

Enrico Di Salle

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-31

Filing date

1993-07-29

Publication date

1996-09-16

1993-07-29 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1996-09-16 Publication of PH29938A publication Critical patent/PH29938A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Percussion Or Vibration Massage (AREA)
Lubricants (AREA)
Glass Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PH46606A 1992-07-31 1993-07-29 Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives PH29938A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB929216284A GB9216284D0 (en)	1992-07-31	1992-07-31	Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Publications (1)

Publication Number	Publication Date
PH29938A true PH29938A (en)	1996-09-16

Family

ID=10719598

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH46606A PH29938A (en)	1992-07-31	1993-07-29	Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives

Country Status (28)

Country	Link
US (1)	US5407939A (pl)
EP (1)	EP0607400B1 (pl)
JP (1)	JP3325025B2 (pl)
KR (1)	KR100311547B1 (pl)
CN (1)	CN1041096C (pl)
AT (1)	ATE159951T1 (pl)
AU (1)	AU660562B2 (pl)
CA (1)	CA2120343A1 (pl)
CZ (1)	CZ286240B6 (pl)
DE (1)	DE69315050T2 (pl)
DK (1)	DK0607400T3 (pl)
ES (1)	ES2110620T3 (pl)
FI (1)	FI113778B (pl)
GB (1)	GB9216284D0 (pl)
GR (1)	GR3025546T3 (pl)
HU (2)	HUT67043A (pl)
IL (1)	IL106520A (pl)
MX (1)	MX9304579A (pl)
MY (1)	MY109633A (pl)
NO (1)	NO305401B1 (pl)
NZ (1)	NZ254787A (pl)
PH (1)	PH29938A (pl)
PL (1)	PL178591B1 (pl)
RU (1)	RU2125061C1 (pl)
TW (1)	TW286319B (pl)
UA (1)	UA41291C2 (pl)
WO (1)	WO1994003475A1 (pl)
ZA (1)	ZA935481B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT674521E (pt) *	1992-12-18	2001-10-31	Merck & Co Inc	Metedo para o tratamento da prostatite cronica com 17beta-n-carbamoil monossubstituido-4-aza-5alfa-androst-1-en-3-onas
ES2173889T3 (es) *	1993-06-24	2002-11-01	Richter Gedeon Vegyeszet	Nuevo procedimiento para preparar derivados de 4-azaandrostano 17 beta-sustituidos.
TW369521B (en) *	1993-09-17	1999-09-11	Smithkline Beecham Corp	Androstenone derivative
BR9407866A (pt) *	1993-10-21	1996-10-29	Merck & Co Inc	Composto processos para inibiçao de 5 -redufase ou isoenzimas da mesma paratratamento de condiçoes de acne vulgar alopécia androgènica hirsutismo feminino hiperplasia prostática benigna prostatite e para o tratamento e/ou prevençao do cancer da próstata para interrupçao e reversao de alopécia androgènica e promoçao do crescimento de cabelo em um mamifero e para inibiçao de conversao biossintética da testosterona para di-hidro- testosterona em um mamifero e composiçao farmacèutica
GB9415178D0 (en) *	1994-07-28	1994-09-21	Erba Carlo Spa	4-azasteroids with side-chain fluoroketones
US5541322A (en) *	1994-10-14	1996-07-30	Glaxo Wellcome Inc.	Synthesis of 6-azaandrostenones
US5543417A (en) *	1994-10-21	1996-08-06	Merck & Co., Inc.	Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US5595996A (en) *	1994-10-25	1997-01-21	Merck & Co., Inc.	7-substituted 4-aza cholanic acid derivatives and their use
IT1275594B1 (it) *	1995-07-21	1997-08-06	Pharmacia S P A Ora Pharmacia	Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
GB9518858D0 (en) *	1995-09-14	1995-11-15	Pharmacia Spa	Phenylsubstituted 4-azasteroid fluoroderivatives
GB9727522D0 (en) *	1997-12-31	1998-02-25	Pharmacia & Upjohn Spa	Process for preparing carboxamido-4-azasteroids
US6645974B2 (en) *	2001-07-31	2003-11-11	Merck & Co., Inc.	Androgen receptor modulators and methods for use thereof
PL372920A1 (pl) *	2002-03-13	2005-08-08	Merck & Co,Inc.	Fluorowane pochodne 4-azasteroidowe jako modulatory receptora androgenowego
CA2530182A1 (en)	2003-06-30	2005-01-20	Merck & Co., Inc.	17-acetamido-4-azasteroid derivatives as androgen receptor modulators
US7696217B2 (en) *	2003-06-30	2010-04-13	Merck Sharp & Dohme Corp.	17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CA2530047A1 (en) *	2003-06-30	2005-02-03	Merck & Co., Inc.	17-acetamido-4-azasteroid derivatives as androgen receptor modulators
AU2004255200A1 (en) *	2003-06-30	2005-01-20	Merck & Co., Inc.	17-acetamido-4-azasteroid derivatives as androgen receptor modulators
US7446110B2 (en) *	2003-09-10	2008-11-04	Merck & Co., Inc.	17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
EP1670483A4 (en)	2003-09-10	2010-02-17	Merck & Co Inc	17-heterocyclic 4-azasteroid derivatives as androgen receptor modules
CA2562132A1 (en) *	2004-04-08	2005-10-27	Merck & Co., Inc.	17 beta-acetamide-4-azasteroids as androgen receptor modulators
US20100105700A1 (en) *	2008-10-28	2010-04-29	Lead Therapeutics, Inc.	Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
KR102541494B1 (ko)	2019-09-11	2023-06-08	주식회사 엘지화학	고흡수성 수지의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ211145A (en) *	1984-02-27	1988-10-28	Merck & Co Inc	4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
GB8505862D0 (en) *	1985-03-07	1985-04-11	Erba Farmitalia	Steroidic 5alpha-reductase inhibitors
GB9002922D0 (en) *	1990-02-09	1990-04-04	Erba Carlo Spa	17 beta-substituted-4-aza-5 alpha-androstan-3-one derivatives and process for their preparation
IE76452B1 (en) *	1990-10-29	1997-10-22	Sankyo Co	Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) *	1991-10-09	1994-04-19	Ciba-Geigy Corporation	17β-substituted Aza-androstane derivatives
AUPP930799A0 (en) *	1999-03-18	1999-04-15	University Of Sydney, The	Optical planar waveguide device and method of its fabrication

1992
- 1992-07-31 GB GB929216284A patent/GB9216284D0/en active Pending
1993
- 1993-07-28 CZ CZ19931538A patent/CZ286240B6/cs not_active IP Right Cessation
- 1993-07-29 HU HU9400914A patent/HUT67043A/hu unknown
- 1993-07-29 CA CA002120343A patent/CA2120343A1/en not_active Abandoned
- 1993-07-29 KR KR1019940701034A patent/KR100311547B1/ko not_active Expired - Fee Related
- 1993-07-29 AU AU47048/93A patent/AU660562B2/en not_active Ceased
- 1993-07-29 NZ NZ254787A patent/NZ254787A/en unknown
- 1993-07-29 MY MYPI93001489A patent/MY109633A/en unknown
- 1993-07-29 PH PH46606A patent/PH29938A/en unknown
- 1993-07-29 IL IL106520A patent/IL106520A/xx not_active IP Right Cessation
- 1993-07-29 MX MX9304579A patent/MX9304579A/es not_active IP Right Cessation
- 1993-07-29 EP EP93917705A patent/EP0607400B1/en not_active Expired - Lifetime
- 1993-07-29 AT AT93917705T patent/ATE159951T1/de not_active IP Right Cessation
- 1993-07-29 US US08/098,729 patent/US5407939A/en not_active Expired - Fee Related
- 1993-07-29 ES ES93917705T patent/ES2110620T3/es not_active Expired - Lifetime
- 1993-07-29 DK DK93917705.1T patent/DK0607400T3/da active
- 1993-07-29 UA UA94005429A patent/UA41291C2/uk unknown
- 1993-07-29 DE DE69315050T patent/DE69315050T2/de not_active Expired - Fee Related
- 1993-07-29 JP JP50499494A patent/JP3325025B2/ja not_active Expired - Fee Related
- 1993-07-29 WO PCT/EP1993/002037 patent/WO1994003475A1/en not_active Ceased
- 1993-07-29 ZA ZA935481A patent/ZA935481B/xx unknown
- 1993-07-29 RU RU94021145A patent/RU2125061C1/ru not_active IP Right Cessation
- 1993-07-29 CN CN93109305A patent/CN1041096C/zh not_active Expired - Fee Related
- 1993-07-29 PL PL93303048A patent/PL178591B1/pl not_active IP Right Cessation
- 1993-07-29 TW TW082106069A patent/TW286319B/zh active
1994
- 1994-03-24 NO NO941080A patent/NO305401B1/no unknown
- 1994-03-28 FI FI941424A patent/FI113778B/fi not_active IP Right Cessation
1995
- 1995-06-30 HU HU95P/P00706P patent/HU211238A9/hu unknown
1997
- 1997-12-02 GR GR970403195T patent/GR3025546T3/el unknown

Also Published As

Publication number	Publication date
JPH06511497A (ja)	1994-12-22
JP3325025B2 (ja)	2002-09-17
DE69315050T2 (de)	1998-03-05
AU4704893A (en)	1994-03-03
AU660562B2 (en)	1995-06-29
IL106520A0 (en)	1993-11-15
ZA935481B (en)	1994-05-16
CA2120343A1 (en)	1994-02-17
EP0607400B1 (en)	1997-11-05
NO305401B1 (no)	1999-05-25
CZ286240B6 (cs)	2000-02-16
GB9216284D0 (en)	1992-09-16
DE69315050D1 (de)	1997-12-11
ATE159951T1 (de)	1997-11-15
HU9400914D0 (en)	1994-06-28
GR3025546T3 (en)	1998-03-31
NZ254787A (en)	1995-11-27
FI941424A0 (fi)	1994-03-28
IL106520A (en)	1997-11-20
RU2125061C1 (ru)	1999-01-20
PL178591B1 (pl)	2000-05-31
MY109633A (en)	1997-03-31
FI113778B (fi)	2004-06-15
FI941424A7 (fi)	1994-05-27
HUT67043A (en)	1995-01-30
HU211238A9 (en)	1995-11-28
CN1041096C (zh)	1998-12-09
CZ153893A3 (en)	1994-02-16
KR100311547B1 (ko)	2002-06-20
NO941080L (no)	1994-05-18
TW286319B (pl)	1996-09-21
ES2110620T3 (es)	1998-02-16
WO1994003475A1 (en)	1994-02-17
UA41291C2 (uk)	2001-09-17
CN1085224A (zh)	1994-04-13
DK0607400T3 (da)	1998-01-26
HK1011693A1 (en)	1999-07-16
EP0607400A1 (en)	1994-07-27
NO941080D0 (no)	1994-03-24
US5407939A (en)	1995-04-18
MX9304579A (es)	1994-02-28

Publication	Publication Date	Title
PH29938A (en)	1996-09-16	Fluorinated 17beta- substituted 4-aza-5alpha androstane-3-one derivatives
AU555323B2 (en)	1986-09-18	Esters of phosphinyl alkanoyl substituted prolines
AU5898580A (en)	1981-01-08	Pyroglutamic acid derivatives
DK0551849T3 (da)	1997-03-10	Arylcycloalkylderivater, deres fremstilling og anvendelse
DE3876813D1 (de)	1993-02-04	3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
AU596389B2 (en)	1990-05-03	1-arylpyrazoles
DK0490566T3 (da)	1994-11-14	Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
CA2003172A1 (en)	1990-05-18	Certain 2-(2',3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones
LU91031I2 (en)	2003-09-01	Zaxem
IE45590L (en)	1978-03-17	Anilines.
ATE386724T1 (de)	2008-03-15	Substituierte hexahydrobenzo(a) phenanthridine
AU551618B2 (en)	1986-05-08	Pyridazinone derivatives
MY103245A (en)	1993-05-29	Antiarrhythmic agents
GR3029428T3 (en)	1999-05-28	Novel bisoxadiazolidine derivative
MX9505054A (es)	1997-01-31	Derivados de ester de bisfenol.
ES2102327A1 (es)	1997-07-16	Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
GR3031864T3 (en)	2000-02-29	Methotrexate derivative.
ES8801669A1 (es)	1988-02-16	Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
ES2001102A6 (es)	1988-04-16	Un procedimiento para la preparacion de un derivado de indeno.
SG47940A1 (en)	1998-04-17	Light screening agent
GB2003866A (en)	1979-03-21	Thiourea derivatives
TW358809B (en)	1999-05-21	Phenylamidinothiophene compound and anti-inflammatory agent containing the same
EP0443474A3 (en)	1992-04-22	1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
MX9706627A (es)	1997-11-29	Derivado de tiazolidinona opticamente activo.